Trial Profile
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2018
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 05 May 2016 Status changed from active, no longer recruiting to completed.
- 31 Mar 2016 Planned End Date changed from 1 Jun 2015 to 1 May 2016 as reported by ClinicalTrials.gov.
- 25 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 May 2015, as reported by ClinicalTrials.gov.